Just over a year ago, we provided a bird’s eye view of the quant data landscape – from credit card transactions to sentiment. Today, we revisit this space to discuss the state of the market and how momentum has developed among incumbents and challengers in 2024.

Interest rates remain high, deal flow remains down and private equity firms have adopted new strategies to remain active in the market. This intelligence report seeks to outline some of the trends we have seen in 2024 and analyse how PE firms can use alternative data to better inform new strategies.

Environmental, social, governance – three words that have become so politically charged that funds are dropping the terms (jobs cuts and merging teams) amid capital outflows and declining demand. In this piece, we talk through some of the controversies surrounding ESG and highlight potential silver linings across the three pillars for risk mitigation and alpha generation.

Just 5% of alternative data buyers expect their budgets to fall in 2025, according to Neudata’s Industry Trends Survey 2024. Data buyers responding to the survey represent roughly $100m in annual spend, while vendor respondents generate a total of over $650m in revenue from data sales. We asked about data costs, trials, pain points, popular categories and, of course, AI. In this report, we reveal our findings.

The ability to leverage new datasets is an increasingly important differentiator for investment managers to stay ahead of the competition. In this report, we highlight novel datasets that may be worth considering.

The quality and diversity of training data can determine the success or failure of AI models. In this article, we explore the growing market for training data.

Determining the trajectory of consumer spending with high-frequency alternative sources can offer investors a timely advantage. In this report, we summarise key dataset types and highlight where they can be found.

As dealers and manufacturers turn to incentives to shift stock, we highlight datasets that can be used to forecast the revenue of auto manufacturers.

As healthcare stocks continue to outperform other sectors, we examine the evolving data landscape for tracking medical device utilisation.

We look at the use case for receipt data in understanding changes in shopping behaviour, highlighting key providers in the space to be aware of.